Pm. Dobadoberrios et al., EFFECTS OF MORPHINE AND NALOXONE ON PROLACTIN AND GROWTH-HORMONE GENE-EXPRESSION IN THE MALE-RAT PITUITARY-GLAND, Journal of neuroendocrinology, 5(5), 1993, pp. 553-556
It is generally admitted that opioids can stimulate the release of bot
h prolactin (PRL) and growth hormone (GH). In order to investigate the
role of opioids in the regulation of PRL and GH gene expression in th
e rat pituitary, we studied the effects of chronic administration of t
he opioid drug morphine and an opiate receptor antagonist naloxone on
both PRL and GH gene expression as measured by in situ hybridization.
Four-day treatment with morphine (40 mg/kg/day) produced a 12% increas
e in PRL mRNA levels. Conversely, naloxone (4 mg/kg/day) decreased the
autoradiographic reaction by 10%. The concomitant administration of m
orphine and naloxone induced no significant changes in PRL gene expres
sion. On the other hand, treatment with morphine produced a 22% decrea
se in GH mRNA levels, an effect which was prevented by the concomitant
administration of naloxone. When injected alone, naloxone did not mod
ify the hybridization signal. These results clearly indicate that opio
ids are involved not only in the regulation of GH and PRL release but
also in the gene expression of the two hormones. The discordance obser
ved between the acute effects of morphine on GH release and the effect
of the opioid drug on mRNA levels remains to be clarified.